Literature DB >> 6980958

Zinc sensitivity of Trichomonas vaginalis: in vitro studies and clinical implications.

J N Krieger, M F Rein.   

Abstract

The high zinc concentration (2.3-15.3 mM) in human prostatic secretions may be an important defense of the male lower urinary tract against infection by Trichomonas vaginalis. Trichomonads were rapidly killed by zinc salts at concentrations similar to those in prostatic fluid of normal men. There was some variation in the zinc sensitivity of 15 clinical isolates of T. vaginalis (minimal inhibitory concentration, 0.8-6.4 mM). A time-kill technique showed subtle differences in the kinetics of zinc killing of trichomonad strains. It was possible to select relatively zinc-resistant substrains of T. vaginalis from a zinc-sensitive population. Zinc resistance was a stable characteristic after multiple passages of substrains in growth medium without supplemental zinc. Variations in the zinc sensitivity of infecting T. vaginalis strains or in the zinc content of host prostatic secretions may be significant determinants of the natural history of T. vaginalis infection in men.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6980958     DOI: 10.1093/infdis/146.3.341

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Survival of Trichomonas vaginalis in human semen.

Authors:  J J Daly; J K Sherman; L Green; T L Hostetler
Journal:  Genitourin Med       Date:  1989-04

Review 2.  Non-specific microbicide product development: then and now.

Authors:  Joseph W Romano; Melissa Robbiani; Gustavo F Doncel; Thomas Moench
Journal:  Curr HIV Res       Date:  2012-01-01       Impact factor: 1.581

3.  Trichomoniasis in older individuals: a preliminary report from Iran.

Authors:  Zohreh Momeni; Javid Sadraei; Bahram Kazemi; Abdolhossein Dalimi
Journal:  J Parasit Dis       Date:  2016-01-12

4.  Electron microscopic study of the effect of zinc on Tritrichomonas foetus.

Authors:  M Benchimol; J C Almeida; U Lins; N R Gonçalves; W de Souza
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

Review 5.  Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.

Authors:  Sarah L Cudmore; Kiera L Delgaty; Shannon F Hayward-McClelland; Dino P Petrin; Gary E Garber
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

6.  Viability of Trichomonas vaginalis in vitro at four temperatures.

Authors:  R F Smith
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

7.  Use of a time-kill technique for susceptibility testing of Trichomonas vaginalis.

Authors:  J N Krieger; C S Dickins; M F Rein
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

8.  Trichomonal vaginitis refractory to treatment: case report.

Authors:  M S Sprott; A M Kearns; R S Pattman
Journal:  Genitourin Med       Date:  1988-12

9.  Venereal trichomoniasis: role of men.

Authors:  J G Langley; J M Goldsmid; N Davies
Journal:  Genitourin Med       Date:  1987-08

Review 10.  Prostatitis.

Authors:  G J Domingue; W J Hellstrom
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.